Suppr超能文献

谷胱甘肽致突变性的机制及相关性。

Mechanism and relevance of glutathione mutagenicity.

作者信息

Ross D, Moldeus P, Sies H, Smith M T

出版信息

Mutat Res. 1986 Nov;175(3):127-31. doi: 10.1016/0165-7992(86)90110-7.

Abstract

The ubiquitous tripeptide glutathione (GSH) has previously been shown to be mutagenic to Salmonella typhimurium TA100 when incubated with kidney subcellular fractions at physiological concentrations (Glatt et al., 1983). Here we report that the mutagenic effect of GSH can be inhibited by the use of the gamma-glutamyl-transpeptidase (gamma-GT) inhibitor anthglutin and by the metal chelators bathocuproine, EDTA and diethyldithiocarbamate. As the chelating agents did not inhibit gamma-GT activity this suggested that the mechanism underlying the mutagenic effect of GSH was at least a two-step process, dependent upon the cleavage of GSH by gamma-GT and the presence of either free transition metals or those contained in enzymes such as glutathione oxidase. As gamma-GT is located on the outer surface of kidney tubule cells and is therefore exposed to relatively low concentrations of GSH, and the precise physiological control of levels of transition metals, this mechanism is unlikely to occur in vivo.

摘要

普遍存在的三肽谷胱甘肽(GSH)先前已被证明,当与肾脏亚细胞组分在生理浓度下孵育时,对鼠伤寒沙门氏菌TA100具有致突变性(Glatt等人,1983年)。在此我们报告,谷胱甘肽转肽酶(γ-GT)抑制剂蒽黄素以及金属螯合剂bathocuproine、EDTA和二乙基二硫代氨基甲酸盐可抑制谷胱甘肽的致突变作用。由于螯合剂不抑制γ-GT活性,这表明谷胱甘肽致突变作用的机制至少是一个两步过程,取决于γ-GT对谷胱甘肽的裂解以及游离过渡金属或谷胱甘肽氧化酶等酶中所含过渡金属的存在。由于γ-GT位于肾小管细胞的外表面,因此暴露于相对较低浓度的谷胱甘肽,以及过渡金属水平的精确生理控制,这种机制不太可能在体内发生。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验